glp 1 and itchy skin Exploring the Role of GLP-1 Receptor Agonists in Psoriasis A Closer Look at the

Dysesthesia: A New Signal for Retatrutide The TRIUMPH-4 Phase 3 trial revealed an unexpected finding: dysesthesia (abnormal touch sensations where normal sensations feel unusual or painful) in 20.9% of participants on 12 mg and 8.8% on 9 mg, compared to 0.7% on placebo (BioSpace, Dec 2025)

In general, Canada researchers think that BPC-157 promotes healing, lowers inflammation, and supports general tissue health and well-being by combining angiogenic, anti-inflammatory, and antioxidant mechanisms

Obesity and cardiovascular disease: A scientific statement from the american heart association

PlexusDx eliminates these barriers by operating on transparent, inclusive pricing with no membership fees, insurance requirements, or surprise charges